30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Alnylam Pharmaceuticals Inc. (ALNY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | VenBio Select Advisor Kurt Von Emster | 1,111,111 | $212,677,757 | +10% | 2.93% |
| 2. | 55,000,000 | $54,514,900 | 2.82% | ||
| 3. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 235,000 | $44,981,350 | -16% | 1.1% |
| 4. | 228,600 | $43,756,326 | 15.63% | ||
| 5. | 40,500,000 | $39,993,750 | +35% | 1.59% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $71.87 | 297,501 | Large Shareholder | 10,554,134 | 2017-05-31 | Filing | |
| $65.35 | 11,500 | Officer | 11,500 | 2017-05-30 | Filing | |
| $37.00 | 27,900 | Director | 27,900 | 2016-10-13 | Filing | |
| $58.36 | 2,000 | Director | 4,000 | 2016-03-09 | Filing | |
| $69.75 | 205,030 | Large Shareholder | 10,256,633 | 2016-02-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $156.54 | 516 | Director | 0 | 2024-02-29 | Filing | |
| $154.07 | 101 | Director | 516 | 2024-02-29 | Filing | |
| $153.62 | 1,906 | Director | 617 | 2024-02-29 | Filing | |
| $152.40 | 915 | Director | 2,523 | 2024-02-29 | Filing | |
| $151.43 | 13,557 | Director | 3,438 | 2024-02-29 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 16,174,563 | $3,096,023,554 | 0.55% | |
| 2. | 11,943,895 | $2,286,180,943 | 0.05% | |
| 3. | 10,312,356 | $1,973,888,016 | 0.15% | |
| 4. | 8,521,115 | $1,631,026,620 | 0.04% | |
| 5. | 7,214,198 | $1,380,869,641 | 0.25% |
News See All
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q4 2023 Earnings Call Transcript
Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-1.1, expectations were $-1.2.
13 Most Promising Healthcare Stocks According to Analysts
In this article, we discuss the 13 most promising healthcare stocks according to analysts.
30 Largest Pharmaceutical Companies in the World
In this article, we will be taking a look at the 30 largest pharmaceutical companies in the world.
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q3 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Alnylam Pharmaceuticals Q3 2023 Earnings Conference Call. At this time, participants are in a listen-only mode.
13 Best Beaten Down Stocks To Buy Now
In this article, we will be taking a look at the 13 best beaten down stocks to buy now.
18 Best 52-Week Low Stocks To Buy Now
US stock markets are jittery after Fed Chair Jerome Powell made it clear that inflation is still high and needs further taming.
15 Worst Performing Biotech Stocks in 2023
In this article, we discuss 15 worst performing biotech stocks in 2023.
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q2 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Alnylam Pharmaceuticals Q2 2023 Earnings Conference Call. At this time, participants are in a listen-only mode.
Billionaire Hedge Funds
